Organisation
Hepatology
Division
The labo of Hepatology studies pathophysiology and treatment of liver and pancreas diseases and metabolism.
Projects
31 - 40 of 51
- METABOLOMIC PROFILING OF PATIENTS WITH INBORN ERRORS OF METABOLISMFrom31 Aug 2017 → 21 Sep 2021Funding: Own budget, for example: patrimony, inscription fees, gifts
- TAMALE: Tracer-bAsed MApping of Liver mEtabolismFrom1 Aug 2017 → 31 Jul 2019Funding: BOF - Bilateral scientific cooperation
- The role of cytopathology in the management of patients with pancreatic tumours - special focus on neuroendocrine tumoursFrom15 Jun 2017 → 17 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Development of a novel diagnotic assay for the biochemical diagnosis of mitochondrial disorders in vital tissueFrom1 Jan 2017 → 30 Sep 2019Funding: FWO Applied Biomedical Research (TBM)
- Hepatitis C virus direct acting antiviral (DAA) treatment success and its impact on transmission dynamics in HIV/HCV co-infected MSMFrom1 Jan 2017 → 31 Dec 2020Funding: FWO research project (including WEAVE projects)
- Academic Center for Research On Nutritional health In ManFrom1 May 2016 → 30 Apr 2020Funding: FWO Medium Size Research Infrastructure
- The role of macrophage activation in the development of Non-alcoholic steatohepatitis: an integrated study of the gut-fat-liver axis.From1 May 2014 → 30 Apr 2015Funding: Foreign foundations, funds with scientific view
- Host and environmental factors influencing the intestinal microbiota in ulcerative colitis and primary sclerosing cholangitisFrom1 Oct 2013 → 15 Dec 2017Funding: Own budget, for example: patrimony, inscription fees, gifts
- Interaction of microbiota with intestinal macrophages in chronic liver diseases. The role of the epithelial barrier.From1 Oct 2013 → 30 Sep 2018Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rare diseases and orphan drugs: patient values, market trends and misconceptions.From1 Oct 2013 → 11 Jan 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
Publications
1 - 10 of 1341
- OPTIMAL TIMING OF ENDOSCOPY IS ASSOCIATED WITH LOWER 42-DAY MORTALITY IN VARICEAL BLEEDING(2019)
Authors: Stig B Laursen, Adrian J Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Candido V Sanchez, Dominique Thabut, Luis Ibanez-Samaniego, Javier Martinez, Joan Genesca, et al.
Pages: AB95 - AB95 - LONG-TERM EFFICACY AND SAFETY OF OBETICHOLIC ACID IN PRIMARY BILIARY CHOLANGITIS: RESPONDER ANALYSIS OF OVER 5 YEARS OF TREATMENT IN THE POISE TRIAL(2020)
Authors: Bettina E Hansen, David Jones, Marco Carbone, Christopher L Bowlus, Frederik Nevens, Andreas E Kremer, Alexander Liberman, Leigh MacConell, Gideon M Hirschfield
Pages: 752A - 752A - Optimal timing of endoscopy is associated with lower 42-day mortality in variceal bleeding(2019)
Authors: Stig Borbjerg Laursen, Adrian Stanley, Virginia Hernandez-Gea, Bogdan Procopet, Alvaro Giraldez, Lucio Amitrano, Candid Villanueva, Dominique Thabut, Luis Ibanez-Samaniego, Gilberto Silva-Junior, et al.
Pages: E16 - E17 - Elevated alkaline phosphatase predicts response in polycystic liver disease during somatostatin analogue therapy: a multi-center pooled analysis on individual patient data(2014)
Authors: Tom J Gevers, Frederik Nevens, Vicente E Torres, Marie C Hogan, Joost Drenth
Pages: 431A - 431A - HIGH-THROUGHPUT SEQUENCING OF THE HUMAN HEPATIC PROGENITOR CELL NICHE REVEALS DIFFERENT SIGNALLING PATHWAYS DEPENDING ON THE UNDERLYING CHRONIC LIVER DISEASE(2015)
Authors: Olivier Govaere, Jasper Wouters, Wouter Van Delm, R van Eijsden, An Ceulemans, Werner Van Steenbergen, Diethard Monbaliu, Frederik Nevens, Tania Roskams
Pages: S239 - S239 - Increasing the Tolerance for Warm Ischemia of Liver Grafts from DCD Donors by the Leuven Drug Protocol(2011)
Authors: Jos van Pelt, Katrien Vekemans, Diethard Monbaliu, E Balligand, Veerle Heedfeld, Jacques Pirenne
Pages: 437 - 437 - Treatment of Hepatorenal syndrome(2009)
Authors: Frederik Nevens
Pages: 548 - 554 - Hepatitis C genotype 4 response rate to pegylated interferon and ribavirin treatment in Belgium is similar to genotype 1(2010)
Authors: Frederik Nevens
Pages: 229 - 234 - The H2304E1 Study: Efficacy and Safety of Everolimus With Reduced Tacrolimus Versus Standard Tacrolimus in De Novo Liver Transplant Recipients at 36 Months.(2014)
Authors: P De Simone, GM Kaiser, L De Carlis, HJ Metselaar, C Duvoux, Frederik Nevens, L Fischer, J Fung, G Dong, B Rauer, et al.
Pages: S106 - S106 - EVEROLIMUS-BASED IMMUNOSUPPRESSION IN HCV POSITIVE DE NOVO LIVER TRANSPLANT RECIPIENTS: 24-MONTH RESULTS OF A RANDOMIZED CONTROLLED TRIAL(2013)
Authors: F Saliba, HJ Metselaar, S Beckebaum, C Duvoux, M Navasa, G Dong, P Lopez, Frederik Nevens
Pages: S79 - S80